The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma

Background: The association between contrast enhanced (CE) and non-contrast enhanced (NCE) tumor resection and survival in patients with glioblastoma in relation to molecular subtypes is poorly understood. The aim of this study was to assess the association between CE and NCE tumor resection and sur...

Full description

Bibliographic Details
Main Authors: Fatih Incekara, Marion Smits, Sebastian R. van der Voort, Hendrik Jan Dubbink, Peggy N. Atmodimedjo, Johan M. Kros, Arnaud J. P. E. Vincent, Martin van den Bent
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01087/full
id doaj-bc7d65cb5dab46aa8884ea83479cffbc
record_format Article
spelling doaj-bc7d65cb5dab46aa8884ea83479cffbc2020-11-25T03:45:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-07-011010.3389/fonc.2020.01087550278The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype GlioblastomaFatih Incekara0Fatih Incekara1Marion Smits2Sebastian R. van der Voort3Hendrik Jan Dubbink4Peggy N. Atmodimedjo5Johan M. Kros6Arnaud J. P. E. Vincent7Martin van den Bent8Department of Neurosurgery, Brain Tumor Center, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsDepartment of Neurosurgery, Brain Tumor Center, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsBackground: The association between contrast enhanced (CE) and non-contrast enhanced (NCE) tumor resection and survival in patients with glioblastoma in relation to molecular subtypes is poorly understood. The aim of this study was to assess the association between CE and NCE tumor resection and survival in light of MGMT promoter methylation in newly diagnosed IDH-wildtype glioblastoma.Materials and methods: Patients with newly diagnosed IDH-wildtype glioblastoma who underwent surgery were eligible. CE and NCE tumor volumes were assessed on pre- and post-operative MRI scans and extent of resection was calculated. The association between CE and NCE tumor resection and survival was evaluated using multivariable Cox proportional hazards models and Kaplan Meier estimates.Results: Three hundred and twenty-six patients were included: 177 (54.3%) with and 149 (45.7%) without MGMT methylation. Multivariable Cox proportional hazards models stratified for MGMT methylation identified age ≤ 65y (HR 0.63; 95% CI, 0.49–0.81; p < 0.0001), chemoradiation (HR 0.13; 95% CI, 0.09–0.19; p < 0.0001), maximal CE tumor resection (HR 0.58; 95% CI, 0.39–0.87; p = 0.009), ≥ 30% NCE tumor resection (HR 0.71; 95% CI, 0.53–0.93; p = 0.014), and minimal residual CE tumor volume (HR 0.64; 95% CI, 0.46–0.88 p = 0.007) as being associated with longer overall survival. Kaplan Meier estimates showed that extensive surgery was more beneficial for patients with MGMT methylated glioblastoma.Conclusions: This study shows an association between maximal CE tumor resection, ≥30% NCE tumor resection, minimal residual CE tumor volume, and longer overall survival in patients with newly diagnosed IDH wildtype glioblastoma. Intraoperative imaging and stimulation mapping may be used to pursue safe and maximal resection. In future research, the safety aspect of maximizing tumor resection needs to be addressed.https://www.frontiersin.org/article/10.3389/fonc.2020.01087/fullglioblastomaextent of resectioncontrast enhancednon-contrast enhancedsurvivalMGMT
collection DOAJ
language English
format Article
sources DOAJ
author Fatih Incekara
Fatih Incekara
Marion Smits
Sebastian R. van der Voort
Hendrik Jan Dubbink
Peggy N. Atmodimedjo
Johan M. Kros
Arnaud J. P. E. Vincent
Martin van den Bent
spellingShingle Fatih Incekara
Fatih Incekara
Marion Smits
Sebastian R. van der Voort
Hendrik Jan Dubbink
Peggy N. Atmodimedjo
Johan M. Kros
Arnaud J. P. E. Vincent
Martin van den Bent
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
Frontiers in Oncology
glioblastoma
extent of resection
contrast enhanced
non-contrast enhanced
survival
MGMT
author_facet Fatih Incekara
Fatih Incekara
Marion Smits
Sebastian R. van der Voort
Hendrik Jan Dubbink
Peggy N. Atmodimedjo
Johan M. Kros
Arnaud J. P. E. Vincent
Martin van den Bent
author_sort Fatih Incekara
title The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
title_short The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
title_full The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
title_fullStr The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
title_full_unstemmed The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
title_sort association between the extent of glioblastoma resection and survival in light of mgmt promoter methylation in 326 patients with newly diagnosed idh-wildtype glioblastoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-07-01
description Background: The association between contrast enhanced (CE) and non-contrast enhanced (NCE) tumor resection and survival in patients with glioblastoma in relation to molecular subtypes is poorly understood. The aim of this study was to assess the association between CE and NCE tumor resection and survival in light of MGMT promoter methylation in newly diagnosed IDH-wildtype glioblastoma.Materials and methods: Patients with newly diagnosed IDH-wildtype glioblastoma who underwent surgery were eligible. CE and NCE tumor volumes were assessed on pre- and post-operative MRI scans and extent of resection was calculated. The association between CE and NCE tumor resection and survival was evaluated using multivariable Cox proportional hazards models and Kaplan Meier estimates.Results: Three hundred and twenty-six patients were included: 177 (54.3%) with and 149 (45.7%) without MGMT methylation. Multivariable Cox proportional hazards models stratified for MGMT methylation identified age ≤ 65y (HR 0.63; 95% CI, 0.49–0.81; p < 0.0001), chemoradiation (HR 0.13; 95% CI, 0.09–0.19; p < 0.0001), maximal CE tumor resection (HR 0.58; 95% CI, 0.39–0.87; p = 0.009), ≥ 30% NCE tumor resection (HR 0.71; 95% CI, 0.53–0.93; p = 0.014), and minimal residual CE tumor volume (HR 0.64; 95% CI, 0.46–0.88 p = 0.007) as being associated with longer overall survival. Kaplan Meier estimates showed that extensive surgery was more beneficial for patients with MGMT methylated glioblastoma.Conclusions: This study shows an association between maximal CE tumor resection, ≥30% NCE tumor resection, minimal residual CE tumor volume, and longer overall survival in patients with newly diagnosed IDH wildtype glioblastoma. Intraoperative imaging and stimulation mapping may be used to pursue safe and maximal resection. In future research, the safety aspect of maximizing tumor resection needs to be addressed.
topic glioblastoma
extent of resection
contrast enhanced
non-contrast enhanced
survival
MGMT
url https://www.frontiersin.org/article/10.3389/fonc.2020.01087/full
work_keys_str_mv AT fatihincekara theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT fatihincekara theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT marionsmits theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT sebastianrvandervoort theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT hendrikjandubbink theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT peggynatmodimedjo theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT johanmkros theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT arnaudjpevincent theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT martinvandenbent theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT fatihincekara associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT fatihincekara associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT marionsmits associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT sebastianrvandervoort associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT hendrikjandubbink associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT peggynatmodimedjo associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT johanmkros associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT arnaudjpevincent associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
AT martinvandenbent associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma
_version_ 1724510118826999808